WebMD Exploring Sales Process as Lipitor goes off patent
Maybe it’s Lipitor’s pending loss of patent protection and the drought in pharmaceutical pipelines, or more likely perhaps is the announcement of significant minority shareholder positions by both Carl Icahn and George Soros in recent weeks and the interesting phone calls with management that likely took place since)… Or perhaps is competition from Everyday Health, or maybe it’s just time for Marty Wygod to retire into the sunset and focus exclusively on his horses… whatever the
reasons, industry juggernaut WebMD (WBMD) is exploring options for selling the company to private equity. Interesting timing…
About Post Author
